Leaflet METILPREDNISOLON TEVA 40mg powder for solution for injection
Indicated for: inflammation; autoimmune diseases
Route of administration: injectable
Substance: methylprednisolone (glucocorticoid)
ATC: H02AB04 (Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use, plain | Glucocorticoids)
Use caution if you have glaucoma or increased eye pressure.
This medicine may increase blood sugar.
This medicine may increase the risk of infections.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Do not stop treatment abruptly without medical advice.
Methylprednisolone is a corticosteroid used to treat a wide range of inflammatory and autoimmune conditions. It is indicated for diseases such as rheumatoid arthritis, systemic lupus erythematosus, severe asthma, inflammatory bowel diseases (such as Crohn's disease or ulcerative colitis), severe allergies, dermatitis, multiple sclerosis, and certain types of cancer. It is also used to prevent organ rejection after transplantation.
Methylprednisolone works by suppressing the body's inflammatory and immune response, reducing inflammation, swelling, redness, and pain. It is available in the form of tablets, injectable solutions, or creams, and the method of administration depends on the condition being treated.
The dosage and duration of treatment are determined by the doctor based on the severity of the disease and the patient's response. It is important not to stop treatment abruptly, especially after long-term use, as this can lead to adrenal insufficiency.
Common side effects include increased appetite, weight gain, insomnia, irritability, high blood pressure, fluid retention, and weakened immune function. Long-term use may lead to osteoporosis, diabetes, skin thinning, or Cushing's syndrome.
Patients should strictly follow their doctor's instructions and inform their healthcare provider about other medications they are taking, as methylprednisolone can interact with other treatments. It is also important to avoid exposure to infections, as the medication can weaken the immune response.
General data about METILPREDNISOLON TEVA 40mg
- Substance: methylprednisolone
- Date of latest medicines list: 01-10-2015
- Product code: W61961001
- Concentration: 40mg
- Pharmaceutical form: powder for solution for injection
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for methylprednisolone
Concentrations available for methylprednisolone
- 1000mg
- 125mg
- 125mg/2ml
- 16mg
- 20mg
- 250mg
- 250mg/4ml
- 32mg
- 40mg
- 40mg/1ml
- 40mg/2ml
- 40mg/ml
- 4mg
- 500mg
- 500mg/7.8ml